Table of Contents
Metal-Based Drugs
Volume 5 (1998), Issue 4, Pages 179-188
http://dx.doi.org/10.1155/MBD.1998.179

The Development of Novel Organotin Anti-Tumor Drugs: Structure and Activity

1Medical Department, Pharmachemie BV, PO Box 552, Haarlem NL-003 RN, The Netherlands
2Free University of Brussels VUB, Pleinlaan 2, Department of General and Organic Chemistry, Faculty of Engineering, Brussels B-1050, Belgium
3Free University of Brussels VUB, Pleinlaan 2, High Resolution NMR Centre HNMR, Brussels B-1050, Belgium
4Laboratory for Tumor Biology and Pharmacology, Academic Hospital Rotterdam, PO Box 2040, Rotterdam NL-3000 CA, The Netherlands

Received 18 June 1998; Accepted 14 July 1998

Copyright © 1998 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Dick de Vos, Rudolph Willem, Marcel Gielen, Kyra E. van Wingerden, and Kees Nooter, “The Development of Novel Organotin Anti-Tumor Drugs: Structure and Activity,” Metal-Based Drugs, vol. 5, no. 4, pp. 179-188, 1998. doi:10.1155/MBD.1998.179